Omnicell (MEX:OMCL) Moat Score: 5/10 (As of Jul. 02, 2026)


MEX:OMCL Omnicell Inc MEX:OMCL
65 GF Score
Price MXN761.16
GF Value MXN710.01
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Omnicell Moat Score?

Omnicell MEX:OMCL 65 Moat Score is 5 as of Jul. 02, 2026. GuruFocus rates MEX:OMCL with a GF Score™ of 65/100 and a GF Value™ of MXN710.01 (Fairly Valued). The stock has 6 warning signs investors should review. Among 679 Healthcare Providers & Services companies, Omnicell ranks better than 96.02% on this metric.

Omnicell has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Omnicell has Narrow Moat: Omnicell Inc has a solid narrow moat due to its proprietary technology in medication management solutions and consistent innovation. The company benefits from customer switching costs and a strong distribution network, but faces competition that prevents it from achieving a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Omnicell might have Narrow Moat - Solid narrow moat.

Omnicell  (MEX:OMCL) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Omnicell Moat Score Related Terms

MEX:OMCL vs TDOC, SDGR, OMDA: Moat Score Comparison

For the Health Information Services subindustry, Omnicell's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Omnicell Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Omnicell's Moat Score distribution charts can be found below:

* The bar in red indicates where Omnicell's Moat Score falls into.


MEX:OMCL
65GF Score
Omnicell Inc MEX:OMCL
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Omnicell (MEX:OMCL) has a Moat Score of 5 as of Jul. 02, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Omnicell ranks #27 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 4%.
Is Omnicell's Moat Score too high?
Omnicell's current Moat Score is 5. Based on the distribution chart, Omnicell ranks #27 out of 679 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Omnicell has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Omnicell's Moat Score compare to TDOC and SDGR?
According to the Healthcare Providers & Services industry distribution chart, Omnicell ranks #27 out of 679 companies for Moat Score. This places Omnicell in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Omnicell's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omnicell stock overvalued right now?
Based on GuruFocus' analysis, Omnicell (MEX:OMCL) is currently considered Fairly Valued. The stock's GF Value™ is MXN710.01, compared to a current price of MXN761.16 — trading 7.2% above its estimated fair value. The current Moat Score is 5. Omnicell's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Omnicell (MEX:OMCL), the current Moat Score is 5 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Omnicell (MEX:OMCL) Overvalued in 2026?

Based on GuruFocus' analysis, Omnicell stock appears to be overvalued. The current stock price of MXN761.16 is trading 7.2% above its estimated GF Value™ of MXN710.01. GuruFocus considers Omnicell to be Fairly Valued.

Key valuation signals for MEX:OMCL:

  • Moat Score: 5
  • GF Value™: MXN710.01 vs. price of MXN761.16 (7.2% above fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the MEX:OMCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Omnicell Business Description

Other Exchanges OMCL:USAOC9:Germany
Address 4220 North Freeway, Fort Worth, TX, USA, 76137
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
65GF Score

Get the complete analysis for MEX:OMCL

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN761.16
Price
MXN710.01
GF Value